Usher syndrome type IV: clinically and molecularly confirmed by novel ARSG variants
Usher syndrome (USH) is an autosomal recessively inherited disease characterized by sensorineural hearing loss (SNHL) and retinitis pigmentosa (RP) with or without vestibular dysfunction. It is highly heterogeneous both clinically and genetically. Recently, variants in the arylsulfatase G ( ARSG ) g...
Gespeichert in:
Veröffentlicht in: | Human genetics 2022-11, Vol.141 (11), p.1723-1738 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Usher syndrome (USH) is an autosomal recessively inherited disease characterized by sensorineural hearing loss (SNHL) and retinitis pigmentosa (RP) with or without vestibular dysfunction. It is highly heterogeneous both clinically and genetically. Recently, variants in the arylsulfatase G (
ARSG
) gene have been reported to underlie USH type IV. This distinct type of USH is characterized by late-onset RP with predominantly pericentral and macular changes, and late onset SNHL without vestibular dysfunction. In this study, we describe the USH type IV phenotype in three unrelated subjects. We identified three novel pathogenic variants, two novel likely pathogenic variants, and one previously described pathogenic variant in
ARSG
. Functional experiments indicated a loss of sulfatase activity of the mutant proteins. Our findings confirm that
ARSG
variants cause the newly defined USH type IV and support the proposed extension of the phenotypic USH classification. |
---|---|
ISSN: | 0340-6717 1432-1203 |
DOI: | 10.1007/s00439-022-02441-0 |